Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Fellow

Clinical Pharmacology & Toxicology · Egypt · 2025-11-14

Processing Time
646 days
Decision Date
2025-11-14
Location
Tennessee
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to examine immune system dysfunction and its relationship to serious medical conditions to uncover novel immune-targeted treatment strategies. The work focuses on identifying immunological mechanisms that inform the development of new therapeutic strategies for autoimmune disorders, cardiovascular disease, and inflammatory conditions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses autoimmune and cardiovascular diseases which are major drivers of U.S. mortality and healthcare spending.

2 Well-positioned to Advance the Endeavor Met

The petitioner has an influential research record with 16 publications, high citation percentiles, and funding from the American Heart Association.

3 Waiver Benefit Met

The petitioner's unique expertise in immunological mechanisms and clinical pharmacology makes their continued work beneficial to U.S. public health regardless of a job offer.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Pharmaceutical Sciences and a record of 16 peer-reviewed journal articles with 234 citations. The evidence included two expert recommendation letters and proof of competitive funding from the American Heart Association. USCIS found all three Dhanasar prongs were satisfied due to the high-impact nature of the research and its alignment with national health priorities.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions

Similar Cases

Clinical Researcher

Research and Development · Jordan

WeGreened EB-2 (NIW) approved
New York 64 days 2025-03-04
The petitioner proposes to continue his research into the mechanistic contributions of T and B cells to the pathogenesis of immunodeficiency and immune dysregulation, aiming to identify and develop novel therapeutics for immunological diseases.
View Case

Research Scientist

Biotechnology · Slovenia

WeGreened EB-2 (NIW) approved
New York 64 days 2025-02-24
The petitioner proposes to advance the development of robust immunotherapies designed to overcome contemporary limitations such as impaired cell function and disease resistance. Her work focuses on elucidating novel molecular mechanisms of immune cells to improve patient outcomes in cancer care and autoimmune disease management.
View Case

Business Manager

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved
323 days 2025-06-16
The petitioner proposes to continue her research in the pharmaceutical industry focusing on precision medicine for autoimmune and inflammatory diseases. She utilizes multi-color flow cytometry and genetic variation analysis to identify immune pathways for the development of novel, personalized therapeutics for rare and severe immune-related conditions.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Ohio 90 days 2025-01-24
The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from Egypt

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-11-14.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 646 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Egypt All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist